In8bio, INC Form 4 insider transactions

IN8BIO's CEO, William Tai-Wei Ho, received a retention award in the form of stock options to purchase 500,000 shares of common stock.

Trishna Goswami, Chief Medical Officer of IN8BIO, Inc., was granted a stock option to purchase 250,000 shares of common stock as a retention award.

Director Travis Whitfill acquired stock options in IN8BIO, INC. on June 12, 2024.

Director Luba Greenwood acquired stock options in IN8BIO, INC. on June 12, 2024.

Director Jeremy R. Graff acquired stock options in IN8BIO, INC. on June 12, 2024.

Director Emily Fairbairn acquired stock options in IN8BIO, INC. on June 12, 2024.

Director Corinne Epperly of IN8BIO, INC. reports acquisition of stock options.

Director Peter C. Brandt acquired stock options in IN8BIO, INC. on June 12, 2024.

Director Alan S. Roemer acquired stock options in IN8BIO, INC. on June 12, 2024.